Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
198 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hepatitis B" (198 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
2 Recruiting Hepatitis B Research Network Adult Cohort Study
Condition: Hepatitis B
Intervention:
3 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
4 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
5 Recruiting The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Metacavir Enteric-coated Capsules 80mg;   Drug: Metacavir Enteric-coated Capsules 160mg;   Drug: Metacavir Enteric-coated Capsules 320mg;   Drug: Metacavir Enteric-coated Capsules Placebo 240mg;   Drug: Metacavir Enteric-coated Capsules Placebo 160mg;   Drug: Metacavir Enteric-coated Capsules Placebo 320mg;   Drug: Adefovir Dipivoxil Capsule10mg;   Drug: Adefovir Dipivoxil Capsule Placebo 10mg
6 Recruiting Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Pegasys&Entecavir
7 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
8 Recruiting Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen
Condition: Chronic Hepatitis B
Intervention: Drug: Pegylated interferon alfa-2a plus nucleos(t)ide(s)
9 Recruiting Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix™-B
Condition: Hepatitis B Vaccine
Intervention: Biological: Engerix-B
10 Recruiting Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Condition: Chronic Hepatitis b
Intervention: Drug: Entecavir or Tenofovir
11 Recruiting PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Peginterferon alfa-2a;   Drug: Nucleos(t)ide analogue
12 Recruiting Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Condition: Hepatitis B
Interventions: Drug: Entecavir prophylaxis;   Drug: Observation arm
13 Recruiting Hepatitis B Vaccination in HIV-infected Adults
Condition: Hepatitis B
Intervention: Biological: recombinant HBV vaccine (Hepavax-Gene® Berna, Korea)
14 Recruiting A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy
Condition: Hepatitis B
Intervention: Biological: Engerix™-B Kinder
15 Recruiting Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts
Condition: Hepatitis B
Intervention: Biological: Recombinant Hepatitis B vaccine [(CIGB) La Habana, Cuba]
16 Recruiting Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?
Condition: Hepatitis B
Intervention: Other: HBV core antibodies testing. • Real time PCR testing.
17 Not yet recruiting TAF Switch Study in Hepatitis B Monoinfection
Condition: Hepatitis B
Intervention: Drug: Tenofovir alafenamide fumarate
18 Recruiting Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection
Condition: Chronic Hepatitis B
Interventions: Drug: Telbivudine;   Drug: Placebo
19 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
20 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & Emtricitabine;   Drug: Tenofovir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.